-
-
-
-
-
-
-
BeiGene (BGNE) Announces EU Approval of TEVIMBRA
-
-
-
-
-
-
-
BeiGene (BGNE) Receives Israeli Ministry of Health Approval for TEVIMBRA for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy
-
-
-
-
-
-
-
Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...)
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

